Topics

ViiV files MAA with EMA for approval of HIV drug fostemsavir

04:59 EST 14 Jan 2020 | SmartBrief

ViiV Healthcare, GlaxoSmithKilne's HIV-focused unit, filed a marketing authorization application with the European Medicines  -More

Original Article: ViiV files MAA with EMA for approval of HIV drug fostemsavir

NEXT ARTICLE

More From BioPortfolio on "ViiV files MAA with EMA for approval of HIV drug fostemsavir"

Quick Search

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

AIDS and HIV
AIDS; Acquired Immune Deficiency Syndrome. HIV; Human Immunodeficiency Virus HIV infection causes AIDS. HIV infection also causes the production of anti-HIV antibodies, which forms the test for HIV in patients. People who have the HIV antibodies are ...